Search clinical trials for: Long-acting β2 agonists

Total 13429 results

University of Monastir

Completed

β2-agonist Versus Ipratropium Bromide Associated With β2-agonists in Chronic Obstructive Pulmonary Disease Exacerbation

Acute Exacerbation of Chronic Obstructive Airways Disease

Tunisia
National Heart, Lung, and Blood Institute (NHLBI)
Childhood Asthma Research and Education Network

Completed

Pediatric Asthma Controller Trial (PACT)

Lung Diseases | Asthma
Radboud University Medical Center

Completed

The Effect of Antecedent Hypoglycaemia on β2-adrenergic Sensitivity

Diabetes | Hypoglycemia Unawareness

Netherlands
Hadassah Medical Organization

Unknown

Genetic Determinants of the Response to Salbutamol Among Asthma Patients

Asthma

Israel
Zhongda Hospital

Completed

Predictive Value of β2-microspheres for Postoperative Delirium

Postoperative Delirium

China
Hopital Foch

Active, not recruiting

Corticosteroids/β2-agonists in Hair in Asthmatic Patients (CorticHair) (CorticHair)

Asthma

France
Hadassah Medical Organization

Completed

Vascular Response to Isoproterenol and β2 Adrenergic Receptor Polymorphisms

Coronary Disease

Israel
University of Copenhagen

Completed

Pharmacological Properties of Salmeterol

Pharmacokinetics in Healthy Young Men

Denmark
Novartis

Completed

Safety, Tolerability and Efficacy of Indacaterol in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)

COPD

United States, Argentina, Germany, Spain, Canada, India, Turkey, Sweden, Italy
GlaxoSmithKline

Completed

Study of Salmeterol (SN408D) for Adult Asthma

Asthma | Bronchial Asthma
Isarna Therapeutics GmbH

Completed

Phase I Dose Escalation Study to Investigate the Safety of ISTH0036 in Subjects With Glaucoma Undergoing Trabeculectomy

Primary Open Angle Glaucoma

Germany
Poitiers University Hospital
Baxter Healthcare Corporation

Completed

Comparison of Hemodialysis With Medium Cut-off Dialyzer (Theranova) and High Flux Dialyzer (THERANOVA)

End Stage Renal Disease | Dialysis Related Complication | Dialysis Amyloidosis

France
National Center for Global Health and Medicine,...

Unknown

Utility of Urinary beta2 Microglobulin as an Early Marker of Renal Dysfunction in Vietnamese HIV-Infected Patients

HIV Infection | Renal Function Disorder | Renal Tubular Disorder
Connecticut Children's Medical Center

Completed

B2-Adrenergic Receptor Polymorphisms

Status Asthmaticus

United States
Novartis Pharmaceuticals

Completed

Confirmatory Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

Japan
Novartis Pharmaceuticals

Completed

12-week Open-label Evaluation of Efficacy and Safety of Indacaterol (MOVE-ON)

Chronic Obstructive Pulmonary Disease (COPD)

Israel
Novartis

Completed

Efficacy and Safety of Single Doses of Indacaterol Delivered Via a Single Dose Dry Powder Inhaler (SDDPI) Compared to Placebo in Patients With Persistent Asthma

Asthma

United States
Novartis

Completed

26 Week Efficacy, Safety and Tolerability Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Lung Diseases, Obstructive | Pulmonary Disease, Chronic Obstructive | COPD

United States, Germany, Spain, Argentina, Italy, Turkey, Canada, India, Sweden, Korea, Republic of, Taiwan, Puerto Rico
AstraZeneca

Completed

A Study to Assess the Reduction of Daily Maintenance ICS/LABA Treatment Towards Anti-Inflammatory Reliever Treatment in Patients With Severe Eosinophilic Asthma Treated With Benralizumab

Asthma | Severe Eosinophilic Asthma

France, Germany, Italy, United Kingdom
AstraZeneca

Active, not recruiting

BURAN: Benralizumab on Airway Dynamics in Severe Eosinophilic Asthma Using Functional Respiratory Imaging (BURAN)

Asthma

United States, Belgium, United Kingdom, France, Portugal, Australia, Spain
Boehringer Ingelheim

Completed

Effectiveness of Tiotropium + Olodaterol Versus Inhaled Corticosteroids (ICS) + Long-acting β2-agonists (LABA) Among COPD Patients in Taiwan

Pulmonary Disease, Chronic Obstructive

China
University of Dundee

Completed

Trough Bronchoprotection Conferred by Levosalbutamol and Racemic Salbutamol (NAI009)

Asthma

United Kingdom
Novartis Pharmaceuticals

Completed

Dose Ranging Study for Indacaterol in Japanese Asthma Patients

Asthma

Japan
Novartis Pharmaceuticals

Completed

Safety and Efficacy of Indacaterol Once Daily Versus Salmeterol Twice Daily in Chronic Obstructive Pulmonary Disease (COPD) (INSIST)

Chronic Obstructive Pulmonary Disease (COPD)

United States, Germany, Spain, Turkey, Hungary, Czech Republic, India, Slovakia
Novartis

Completed

Efficacy, Safety, and Tolerability of Once Daily Indacaterol in Chronic Obstructive Pulmonary Disease (COPD) Using Formoterol Twice Daily as Active Control

Chronic Obstructive Pulmonary Disease

Russian Federation, United Kingdom, Spain, Germany, Argentina, Italy, Netherlands, Switzerland, Turkey, France, Czech Republic, Hungary, Slovakia, Peru, Korea, Republic of, Colombia, Israel, Chile, Denmark, Ecuador, Egypt, Estonia, ... and more
Imperial College London
AstraZeneca

Completed

Effect of Symbicort on GR Localisation in Asthma

Asthma

United Kingdom
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Indacaterol in Adults (40 Years and Above) With Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

China, Australia, India
Autotelicbio

Completed

TASO-001 in Combination With Recombinant Interleukin-2(Aldesleukin) in Advanced or Metastatic Solid Tumor

Solid Tumor

Korea, Republic of
Medical University of Warsaw
Jagiellonian University; University of Ottawa; Pomeranian Medical University... and other collaborators

Recruiting

the Inhaled β2-adrenergic Receptor Agonist for Transient Tachypnoea of the Newborn (the REFSAL Trial) (REFSAL)

Respiratory Failure | TTN | PPHN

Poland
Nanjing Maternity and Child Health Care Hospital

Unknown

Correlation Between the Polymorphism ofβ2 AR and the Labor Progress After Labor Analgesia

Labor Analgesia
First Affiliated Hospital of Fujian Medical University

Not yet recruiting

Multi-center Clinical Study on Hemoperfusion of KHA80

Uremia | Dialysis Related Complication | Uremic Osteodystrophy

China
Austin Health

Completed

Study of beta2-Microglobulin Removal by Standard Versus New High Cut-Off Haemodialysis Membrane (HiCOF)

Renal Dialysis

Australia
Novartis Pharmaceuticals

Completed

Confirmatory Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

Taiwan, Korea, Republic of, Japan, India, Hong Kong, Singapore
AstraZeneca

Terminated

A Study to Evaluate the Safety of Tralokinumab in Adults and Adolescents With Uncontrolled Asthma

Inadequately Controlled Asthma

Japan
Academisch Medisch Centrum - Universiteit van Amsterdam...
Dutch Lung Foundation

Completed

Pharmacogenetics Use For Further Treatment Improvement in childreN (PUFFIN)

Asthma in Children

Netherlands, Belgium, Switzerland
University Hospital, Basel, Switzerland

Completed

Beta 2 Adrenergic Stimulation vs Cold Exposure to Activate Human Brown Adipose Tissue (ASCENT)

Thermogenesis

Switzerland
Poitiers University Hospital
Hemotech

Completed

Comparison of the Removal of Uremic Toxins With Medium Cut-off and Super High-flux Vitamin E-coated Dialyzers (E-FLUX)

End Stage Renal Disease (ESRD)

France
Korean Hemodialysis Study Group
Boryung Pharmaceutical Co., Ltd

Unknown

High Versus Standard Volume Hemodiafiltration in Asia

End-stage Renal Disease

Korea, Republic of
National Center for Global Health and Medicine,...

Active, not recruiting

Risk Stratification of COVID-19 Using Urine Biomarkers

Covid19 | Urine | Acute Respiratory Failure With Hypoxia | Biomarker

United States, Brazil, Denmark, Japan, Philippines
AstraZeneca

Completed

Safety and Tolerability of Ciclesonide and Formoterol Fumarate Inhaled Once Daily in Patients With Asthma (18 to 75 y) (BY9010/M1-506)

Asthma

France, Germany, Hungary, South Africa
Novartis

Completed

Dose Ranging Study of Indacaterol in Japanese Patients With Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease

Japan
Isarna Therapeutics GmbH

Completed

Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade Glioma

Glioblastoma | Anaplastic Astrocytoma

Germany, Austria, Georgia, India, Israel, Russian Federation
AstraZeneca

Completed

A Safety Extension Study With Benralizumab for Asthmatic Adults on Inhaled Corticosteroid Plus Long-acting β2 Agonist (MELTEMI)

Asthma

United States, Canada, France, Germany, Spain, United Kingdom, Poland, Turkey, Argentina, Australia, Ukraine, Czechia, Russian Federation, Bulgaria, Chile
Rabin Medical Center

Unknown

Use of Beta-agonists in Stable Severe Congestive Heart Failure

Heart Failure | Ischemic Cardiomyopathy | Non-ischemic Cardiomyopathy

Israel
AstraZeneca

Completed

Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Combinations of Long-acting β2-agonists (LABA) and Inhaled Glucocorticosteroid (ICS) (REACT)

Chronic Obstructive Pulmonary Disease

Korea, Republic of, Austria, Belgium, Germany, Greece, Russian Federation, Australia, Brazil, Canada, Denmark, France, Hungary, Israel, Italy, Netherlands, Poland, Slovakia, South Africa, Spain, Turkey, United Kingdom
GlaxoSmithKline

Completed

Pharmacokinetic and Safety of GSK573719 and GW642444 Administered Individually and Concurrently, With Verapamilin in Healthy Subjects

Pulmonary Disease, Chronic Obstructive

United Kingdom
Laval University
Novartis

Completed

Ultibro® Versus Spiriva® Alone to Reduce Exertional Dyspnea in Patients With Moderate to Severe COPD (RED)

COPD

Canada
AstraZeneca
Parexel

Completed

A Single Inhalation Dose Study to Assess Efficacy, Pharmacokinetics (PK), Safety and Tolerability of AZD8871 in Patients With Long-term Lung Diseases.

Chronic Obstructive Pulmonary Disease

Germany, United Kingdom
GlaxoSmithKline

Completed

A Study to Assess the Safety and Pharmacokinetics of Inhaled Doses of GSK233705 and GW642444 in Healthy Subjects

Pulmonary Disease, Chronic Obstructive

United Kingdom
AstraZeneca
Parexel

Not yet recruiting

Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma (ACADIA)

Asthma

United States

Search clinical trials for: Long-acting β2 agonists

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Italy

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations